ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NICE recommendation for Steglatro in type II diabetes pharmatimes
March 28, 2019The National Institute of Care and Health Excellence (NICE) has recommended MSD’s Steglatro (ertugliflozin) for use within the NHS, for the treatment of adults with type II diabetes.
Pharma Sources Insight January 2025
